1. Subcutaneous apomorphine in Parkinsonian on-off oscillations;Stibe, G.M.H.; Lees, A.J.; Kempster, P.A.; Stern, G.M.;Lancet,1988
2. Administration souscutanee d'apomorphine dans les fluctuations motrices de la maladie de Parkinson;Pollack, P.; Champay, A.S.; Gaio, G.M.; Hommel, M.; Benabib, A.L.; Perret, J.;Rev Neurol,1990
3. Similarities between neurologic effects of the L-Dopa and of apomorphine;Cotzias, G.C.; Papavasiliou, P.S.; Felhing, C.; Kaufman, B.; Mena, I.;N Eng J Med,1970
4. Onset and end of dose levodopa induced dyskinesias;Lhermitte, F.; Agid, Y.; Signoret, J.L.;Arch Neurol,1978
5. Subcutaneous apomorphine in Parkinson's disease;Poewe, W.; Kleedorfer, B.; Gerstenbrand, F.; Oerterl, W.;Lancet,1988